000			nab a22 7a 4500
999			_c17468 _d17468
003			PC17468
005			20230522122019.0
008			230522b xxu||||| |||| 00| 0 eng d
040			_cH12O
041			_aspa, eng
100			_91935 _aMiranda Utrera, Natalia _e Urología
100			_91794 _aMedina Polo, José _eUrología
100			_91933 _aPamplona Casamayor, Manuel _eUrología
100			_91929 _aPassas Martínez, Juan _eUrología
100			_91692 _aRodríguez Antolín, Alfredo _eUrología
100			_91795 _aRosa Kehrman, Federico de la _eUrología
100			_91980 _aDuarte Ojeda, José Manuel _eUrología
100			_9484 _aTejido Sánchez, Ángel _eUrología
100			_9485 _aVillacampa Aubá, Felipe _eUrología
100			_91321 _aAndrés Belmonte, Amado _eNefrología
245	0	0	_aDonantes en asistolia no controlada (tipos i-ii) con recirculación normotérmica versus donantes en muerte cerebral: evaluación de resultados funcionales y supervivencia. _h[artículo]
260			_bActas urológicas españolas, _c2015
300			_a39(7):429-34.
500			_aFormato Vancouver: Miranda Utrera N, Medina Polo J, Pamplona Casamayor M, Passas Martínez JB, Rodríguez Antolín A, de la Rosa Kehrmann F et al. Donantes en asistolia no controlada (tipos i-ii) con recirculación normotérmica versus donantes en muerte cerebral: evaluación de resultados funcionales y supervivencia. Actas Urol Esp. 2015 Sep;39(7):429-34.
501			_aPMID: 25749460
504			_aContiene 22 referencias
520			_aObjective: Non-heartbeating donors (NHBD) are an alternative to heartbeating donors (HBD). Our objective was to compare functional results and kidney survival from NHBDs and HBDs. Material and methods: A retrospective study comparing the results of 236 normothermically preserved kidneys from type i and ii type NHBDs with the results of 250 from HBDs that were transplanted in our center between 2005 and 2012. Homogeneity between groups was tested and we evaluated the presence of delayed graft function (DGF) associated with pretransplant variables of the donor and recipient. Results: Both groups show homogeneity in pretransplant characteristics in terms of: age, HLA incompatibilities, and recipient hemodialysis time. Average follow-up time was 33 months (range 0-87) for NHBDs and 38 months (range 0-90) for HBDs. 5.5% of NHBDs showed primary non-function (PNF) vs. 4% of HBDs (P=.42) and 80.9% of DGF vs. 46.8% of HBDs (P<.001). At the end of the follow-up, there were no statistically significant differences in the survival of grafts (92.8% for NHBD vs. 93.6% for HBD, P=.71) and recipients (99.1% NHBD vs. 98.6% HBD, P=.28). Conclusions: Although the DGF percentage was greater for NHBDs, final creatinine as well as graft and recipient survival were similar for both groups. Therefore, in our experience, kidneys from NHBDs have similar results to those from HBDs and are an excellent source of organs for transplantation.
710			_9220 _aServicio de Urología
710			_986 _aServicio de Nefrología
856			_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/1/pc17468.pdf _ySolicitar documento
942			_2ddc _cART _n0